HEMATOLOGIC DISORDER

Clinical trials for HEMATOLOGIC DISORDER explained in plain language.

Never miss a new study

Get alerted when new HEMATOLOGIC DISORDER trials appear

Sign up with your email to follow new studies for HEMATOLOGIC DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for patients stricken by Immunotherapy's dangerous blood side effects

Disease control Not yet recruiting

This study is testing an experimental drug called golidocitinib for patients with advanced lung cancer. These patients are experiencing severe, hard-to-treat blood-related side effects (like very low blood cell counts) caused by their immunotherapy. The main goal is to see if gol…

Matched conditions: HEMATOLOGIC DISORDER

Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

HEMATOLOGIC DISORDER

Get alerted when new HEMATOLOGIC DISORDER trials appear

New hope for patients stricken by Immunotherapy's dangerous blood side effects